Intercept Pharmaceuticals, Inc. (ICPT)

Nov 8, 2023 - ICPT was delisted (reason: acquired by Alfasigma)
19.00
0.00 (0.00%)
Last trade price

Intercept Pharmaceuticals Market Cap

Intercept Pharmaceuticals is not actively traded anymore. When Intercept Pharmaceuticals last traded, it had a market cap or net worth of $794.36 million.

Market Cap
794.36M
Enterprise Value
694.58M
1-Year Change
92.20%
Ranking
Category
Stock Price
$19.00

Market Cap Chart

Since October 11, 2012, Intercept Pharmaceuticals's market cap has increased from $291.60M to $794.36M, an increase of 172.41%. That is a compound annual growth rate of 9.47%.

History

DateMarket Cap% Change
Nov 7, 2023794.70M0.21%
Nov 6, 2023793.00M-
Nov 3, 2023793.00M-
Nov 2, 2023793.00M0.10%
Nov 1, 2023792.20M0.16%
Oct 31, 2023790.90M0.05%
Oct 30, 2023790.50M0.05%
Oct 27, 2023790.10M-0.16%
Oct 26, 2023791.40M0.64%
Oct 25, 2023786.40M-
Oct 24, 2023786.40M-
Oct 23, 2023786.40M0.81%
Oct 20, 2023780.10M0.05%
Oct 19, 2023779.70M0.27%
Oct 18, 2023777.60M-0.05%
Oct 17, 2023778.00M-0.22%
Oct 16, 2023779.70M2.54%
Oct 13, 2023760.40M-3.97%
Oct 12, 2023791.80M1.18%
Oct 11, 2023782.60M0.54%
Oct 10, 2023778.40M-
Oct 9, 2023778.40M0.15%
Oct 6, 2023777.20M0.06%
Oct 5, 2023776.70M-0.38%
Oct 4, 2023779.70M0.17%
View and export this data all the way back to 2012. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Definitive Healthcare 806.15M
Phreesia 804.94M
NewAmsterdam Pharma Company 800.19M
Inhibrx 799.13M
Kymera Therapeutics 794.86M
Brookdale Senior Living 790.59M
Akero Therapeutics 782.88M
Fulgent Genetics 780.79M
Market Cap Rankings